Skip to main content

Diagnostic options Β· UAE

Immunology tests in Dubai & UAE

Compare available Immunology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

271

Listed price range

450.00–40,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Immunology test prices

Showing 166–180 of 271 matching tests.

Immunology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2144
Immunophenotyping by Flow Cytometry Test

This diagnostic test evaluates maternal lymphocyte subsets, including NK cells, T-helper cells, and T-cytotoxic cells, to assess immune imbalances potentially linked to recurrent p...

Peripheral whole blood (venous) Same day (sample by 9 AM) 1,000.00 AED
View
View test specifications and preparation
What it measures
["Maternal lymphocyte subsets", "Natural Killer (NK) cell count and activation", "T-helper cell count", "T-cytotoxic cell count", "CD56bright/dim NK ratios", "CD69 activation marker", "NK cytotoxicity index"]
Parameters
[{"name": "CD3", "reference_range": null}, {"name": "CD4", "reference_range": null}, {"name": "CD8", "reference_range": null}, {"name": "CD19", "reference_range": null}, {"name": "CD16+56", "reference_range": null}, {"name": "CD56bright/dim ratio", "reference_range": null}, {"name": "CD69 activation", "reference_range": null}, {"name": "NK cytotoxicity index", "reference_range": null}]
Preparation
["No fasting required", "Bring mandatory clinical history form", "Avoid strenuous exercise 24 hours prior", "Avoid alcohol 24 hours prior"]
Indications
["Investigation of immune-mediated recurrent pregnancy loss (RPL)", "Assessment of NK cell function and activation status in pregnancy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96585-0 ICD-10: N96
Clinical summary
This diagnostic test evaluates maternal lymphocyte subsets, including NK cells, T-helper cells, and T-cytotoxic cells, to assess immune imbalances potentially linked to recurrent pregnancy loss.
TEST-2202
Immunophenotyping by Flow Cytometry: Double Negative T Cells (DNT) Test

This diagnostic test quantifies double negative T cells (DNT) in peripheral blood using flow cytometry.

Peripheral whole blood (EDTA and heparin tubes) Next working day (sample received by 9 AM) 850.00 AED
View
View test specifications and preparation
What it measures
["Double Negative T cells (CD3+ TCRΞ±Ξ²+ CD4- CD8-)", "Lymphocyte apoptosis defects"]
Parameters
[{"name": "Double Negative T Cells (DNT)", "reference_range": "
Preparation
["No specific fasting required.", "Do not discontinue prescribed immunosuppressive therapy, corticosteroids, or other medications without consulting your physician."]
Indications
["Suspected autoimmune lymphoproliferative syndrome (ALPS)", "Evaluation of immune dysregulation disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 14105-5 ICD-10: D89.82
Clinical summary
This diagnostic test quantifies double negative T cells (DNT) in peripheral blood using flow cytometry.
TEST-2247
Immunophenotyping by Flow Cytometry: Lymphoma Diagnostic Panel Test

This test evaluates lymphoid cells for specific markers to identify and classify lymphoma subtypes.

Whole blood (EDTA), Bone marrow (Sodium Heparin), Body fluids, Lymph node aspirate Same day (report by evening if sample received by 9 AM) 3,000.00 AED
View
View test specifications and preparation
What it measures
["Cell surface markers", "Cytoplasmic markers", "Nuclear markers", "Lymphoid cell populations"]
Parameters
[]
Preparation
["No fasting required", "Provide complete clinical history and medication list"]
Indications
["Suspicion of lymphoma", "Classification of lymphoid malignancies", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82379-4 ICD-10: C85.9
Clinical summary
This test evaluates lymphoid cells for specific markers to identify and classify lymphoma subtypes.
TEST-1728
Inflammatory Bowel Disease (IBD) Screening Panel Test

This diagnostic test evaluates serological markers and fecal indicators to help differentiate between Crohn's disease and ulcerative colitis.

Blood (Serum/Plasma) and Stool Same Day (Mon–Sat, samples received by 9 AM) 800.00 AED
View
View test specifications and preparation
What it measures
["ASCA IgA", "ASCA IgG", "ANCA", "Calprotectin (Immunoturbidimetry)", "Fecal Occult Blood (Guaiac)"]
Parameters
[{"name": "ASCA IgA", "reference_range": null}, {"name": "ASCA IgG", "reference_range": null}, {"name": "ANCA", "reference_range": null}, {"name": "Calprotectin", "reference_range": null}, {"name": "Fecal Occult Blood", "reference_range": null}]
Preparation
["Refrain from consuming red meat, iron supplements, vitamin C for three full days before collection.", "Avoid using hard-bristle toothbrushes for three full days before collection.", "Overnight fasting (8–12 hours) is required for the blood draw."]
Indications
["Suspected Inflammatory Bowel Disease", "Differentiation between Crohn's disease and ulcerative colitis", "Monitoring disease activity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53843-0 ICD-10: K50.9, K51.9
Clinical summary
This diagnostic test evaluates serological markers and fecal indicators to help differentiate between Crohn's disease and ulcerative colitis.
TEST-42
Infliximab Antibody Test

This test measures the presence and quantity of antibodies against infliximab in a patient's blood.

Serum 2–3 Weeks 4,000.00 AED
View
View test specifications and preparation
What it measures
["Neutralizing antibodies against infliximab", "Non-neutralizing antibodies against infliximab"]
Parameters
[{"name": "Infliximab Antibody Level", "reference_range": "Negative or null"}]
Preparation
["Stop all biotin- or vitamin B7-containing supplements 48 hours before the blood draw.", "Continue all prescribed medications, including infliximab, unless advised otherwise by your doctor."]
Indications
["Monitoring infliximab therapy effectiveness", "Investigating suspected secondary loss of response", "Guiding therapeutic decisions (dose adjustment or drug switch)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90862-2 ICD-10: Z79.899
Clinical summary
This test measures the presence and quantity of antibodies against infliximab in a patient's blood.
TEST-2293
Insulin Antibodies Highly Sensitive Test

This diagnostic test evaluates the presence and level of insulin autoantibodies in the serum.

Serum 2–3 weeks (sample must arrive by the 7th of the month) 2,000.00 AED
View
View test specifications and preparation
What it measures
["Insulin Autoantibodies", "Autoimmune response related to insulin"]
Parameters
[{"name": "Insulin Autoantibodies", "reference_range": "Negative"}]
Preparation
["No specific fasting required.", "Do not discontinue prescribed insulin or oral hypoglycaemic agents without consulting your physician."]
Indications
["Diagnosis of autoimmune diabetes (Type 1)", "Guidance for insulin therapy decisions", "Prediction of disease risk in first-degree relatives", "Suspected Latent Autoimmune Diabetes in Adults (LADA)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3417-8 ICD-10: E10.8, E10.9, E08.0, E08.8
Clinical summary
This diagnostic test evaluates the presence and level of insulin autoantibodies in the serum.
TEST-2260
Insulin Antibodies Test

This diagnostic test evaluates the presence of autoantibodies directed against insulin in the patient's serum.

Serum Same-day if sample collected by 9 AM 450.00 AED
View
View test specifications and preparation
What it measures
["Insulin autoantibodies", "Autoimmune response to insulin"]
Parameters
[{"name": "Insulin Antibodies", "reference_range": null}]
Preparation
["No fasting or special preparation is required."]
Indications
["Diagnosis of autoimmune diabetes", "Evaluation of insulin autoimmune syndrome", "Assessment of unexplained hypoglycemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 9421-4 ICD-10: E10.9
Clinical summary
This diagnostic test evaluates the presence of autoantibodies directed against insulin in the patient's serum.
TEST-2267
Interferon‑Beta IgG Antibody (MAID) Test

This test quantifies IgG antibodies against interferon-beta to assess potential loss of drug efficacy in multiple sclerosis patients.

Serum (peripheral venous blood) 2–3 weeks (batch processing; sample cut‑off on the 7th of each month) 2,500.00 AED
View
View test specifications and preparation
What it measures
["IgG antibodies against interferon-beta", "Binding antibody formation"]
Parameters
[{"name": "Interferon-Beta IgG Antibody", "reference_range": null}]
Preparation
["Collect sample at least 8 hours after interferon injection.", "Inform phlebotomist of current medication, dose, and therapy duration."]
Indications
["Patients with multiple sclerosis receiving interferon-beta therapies (Avonex, Rebif, Betaseron)", "Evaluation of treatment response", "Identification of loss of efficacy due to binding antibody formation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93921-2 ICD-10: G35
Clinical summary
This test quantifies IgG antibodies against interferon-beta to assess potential loss of drug efficacy in multiple sclerosis patients.
TEST-2271
Interleukin-2 Receptor Alpha Chain (IL-2R) Test

This test measures the level of soluble Interleukin-2 Receptor Alpha Chain (sIL-2R or CD25) in the serum, indicating immune system activation.

Serum 2–3 weeks 4,500.00 AED
View
View test specifications and preparation
What it measures
["Soluble Interleukin-2 Receptor Alpha Chain (sIL-2R)", "T-cell activation"]
Parameters
[{"name": "Soluble Interleukin-2 Receptor Alpha Chain (sIL-2R)", "reference_range": null}]
Preparation
["Avoid biotin supplementation within 48 hours", "No specific fasting required"]
Indications
["Diagnosis of autoimmune disorders", "Diagnosis of hemophagocytic lymphohistiocytosis (HLH)", "Diagnosis of lymphomas", "Monitoring disease activity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33933-5 ICD-10: R79.89, D76.1, M35.9
Clinical summary
This test measures the level of soluble Interleukin-2 Receptor Alpha Chain (sIL-2R or CD25) in the serum, indicating immune system activation.
TEST-2310
Interleukin-6 (IL-6) Mini Panel Test

This test quantifies Interleukin-6 (IL-6) levels in serum or plasma to assess systemic inflammation.

Serum or Plasma (EDTA and Citrate tubes) Same-day report (sample received by 4 PM) 750.00 AED
View
View test specifications and preparation
What it measures
["Interleukin-6 (IL-6)", "Systemic inflammation"]
Parameters
[{"name": "Interleukin-6 (IL-6)", "reference_range": null}]
Preparation
["Avoid biotin supplements (>5 mg) for at least 8 hours before collection", "Maintain overnight fasting", "Complete mandatory Coagulation Requisition Form (Form 15)"]
Indications
["Evaluation of systemic inflammatory burden", "Cardiovascular risk assessment", "Monitoring therapy response", "Detection of hidden inflammation", "Monitoring autoimmune conditions", "Guiding longevity programs"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33862-6 ICD-10: R79.89
Clinical summary
This test quantifies Interleukin-6 (IL-6) levels in serum or plasma to assess systemic inflammation.
TEST-2306
Interleukin-6 (IL‑6) Extended Panel Test

This test measures the concentration of Interleukin-6 (IL-6) in serum or plasma to assess systemic inflammation and immune response.

Serum or Plasma (Peripheral Blood) Same-day (sample collected before 4:00 PM) 1,400.00 AED
View
View test specifications and preparation
What it measures
["Interleukin-6 (IL-6)", "Systemic inflammation", "Cytokine release syndromes", "Inflammaging"]
Parameters
[{"name": "Interleukin-6 (IL-6)", "reference_range": null}]
Preparation
["Fasting for 8–10 hours", "Discontinue biotin supplements (>= 5mg/day) at least 8 hours before blood draw", "Do not discontinue prescribed medications without consulting your doctor"]
Indications
["Evaluation of systemic inflammatory states", "Monitoring cytokine release syndromes", "Anti-aging biomarker profiling", "Assessing chronic disease progression", "Immunology", "Rheumatology", "Critical care medicine"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 35358-7 ICD-10: R79.89
Clinical summary
This test measures the concentration of Interleukin-6 (IL-6) in serum or plasma to assess systemic inflammation and immune response.
TEST-2325
Islet Cell Antibody (ICA) Dilution Test

This test measures the level of autoantibodies directed against pancreatic islet cells, aiding in the diagnosis and risk assessment of autoimmune diabetes.

Serum Next day (sample received by 11 AM) 750.00 AED
View
View test specifications and preparation
What it measures
["Islet Cell Autoantibodies", "Pancreatic Islet Cell Autoimmunity"]
Parameters
[{"name": "ICA Titer", "reference_range": "Negative (e.g.,
Preparation
["No fasting or special preparation is required prior to venipuncture."]
Indications
["Diagnosis of Type 1 Diabetes", "Risk assessment for autoimmune diabetes", "Differentiation between Type 1 and Type 2 Diabetes", "Monitoring disease progression in pre-diabetic individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53708-9 ICD-10: E10.9, R73.09, Z13.1
Clinical summary
This test measures the level of autoantibodies directed against pancreatic islet cells, aiding in the diagnosis and risk assessment of autoimmune diabetes.
TEST-2292
Islet Cell Antibody (ICA) Test

This test detects autoantibodies against pancreatic islet cells, indicating an autoimmune process potentially leading to type 1 diabetes.

Serum (gold-top tube) or Plasma (lithium heparin) Next working day (if sample received by 11 AM) 450.00 AED
View
View test specifications and preparation
What it measures
["Autoantibodies directed against cytoplasmic components of pancreatic islet cells"]
Parameters
[{"name": "Islet Cell Antibodies", "reference_range": "Negative"}]
Preparation
["No fasting or special preparation is required"]
Indications
["Screening for autoimmune type 1 diabetes risk", "Evaluation of individuals with recent hyperglycemia", "Assessment in patients with family history of diabetes", "Investigation in patients with other autoimmune diseases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 57890-0 ICD-10: E10.9, Z13.1
Clinical summary
This test detects autoantibodies against pancreatic islet cells, indicating an autoimmune process potentially leading to type 1 diabetes.
TEST-2311
Kappa / Lambda Free Light Chains, Serum Test

This test measures the levels of free kappa and lambda immunoglobulin light chains in the serum to aid in the diagnosis and monitoring of plasma cell disorders.

Serum Same-day results for samples collected before 11 AM (Saturday–Thursday) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Free kappa light chains", "Free lambda light chains", "Kappa/Lambda ratio"]
Parameters
[{"name": "Free Kappa Light Chains", "reference_range": null}, {"name": "Free Lambda Light Chains", "reference_range": null}, {"name": "Kappa/Lambda Ratio", "reference_range": null}]
Preparation
["No special preparation needed", "Fasting is not required", "Inform phlebotomist of any medications"]
Indications
["Suspected multiple myeloma", "Suspected AL amyloidosis", "Monitoring plasma cell disorders", "Assessing minimal residual disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 38497-1 ICD-10: D47.2
Clinical summary
This test measures the levels of free kappa and lambda immunoglobulin light chains in the serum to aid in the diagnosis and monitoring of plasma cell disorders.
TEST-2347
Kappa/Lambda Free Light Chains, Urine Test

This test evaluates the levels of kappa and lambda free light chains in urine, aiding in the diagnosis and monitoring of plasma cell disorders.

Random Midstream Urine Same day (if received by 11 AM) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Kappa free light chains in urine", "Lambda free light chains in urine", "Kappa/Lambda ratio in urine"]
Parameters
[{"name": "Kappa Free Light Chains", "reference_range": "0.1 - 10.0 mg/L"}, {"name": "Lambda Free Light Chains", "reference_range": "0.1 - 10.0 mg/L"}, {"name": "Kappa/Lambda Ratio", "reference_range": "0.26 - 1.65"}]
Preparation
["Collect a random midstream urine sample.", "Refrigerate the sample immediately.", "Contact VIP phlebotomy team at +971 54 548 8731 for cold-chain pickup.", "Freeze the sample if pickup is delayed beyond 4 hours.", "Inform the doctor of all current medications, supplements, and conditions."]
Indications
["Screening for multiple myeloma", "Diagnosis of plasma cell disorders", "Monitoring disease progression or response to treatment", "Assessment of renal involvement in plasma cell dyscrasias"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33935-3 ICD-10: C90.0, C90.1, C90.2
Clinical summary
This test evaluates the levels of kappa and lambda free light chains in urine, aiding in the diagnosis and monitoring of plasma cell disorders.

Category overview

Immunology: overview

When your immune system requires closer attention, obtaining precise answers is the first step toward safeguarding your overall well-being and finding peace of mind. At DNA Labs UAE, our Immunology department utilizes highly advanced automated assay systems to evaluate your body's defense mechanisms. From identifying potential immunodeficiencies to analyzing complex autoimmune responses, our comprehensive immunology testing in the UAE equips your doctor with the vital data needed for effective medical guidance. As one of the most trusted diagnostic labs in Dubai and the UAE, we guarantee strict patient confidentiality alongside fast, highly accurate turnaround times. Take a proactive approach to your immune health today. Browse our immunology diagnostics below, schedule a secure home sample collection, or contact our medical specialists to book your appointment.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area